摘要
目的探讨血液透析与血液灌流联合治疗对长期血液透析患者微炎性因子和钙磷代谢的作用。方法选取2015年1月~2017年2月我院收治的82例长期血液透析患者,随机分为对照组与研究组,各41例。对照组给予血液透析治疗,研究组给予血液透析与血液灌流联合治疗,比较两组的微炎性因子和钙磷代谢水平。结果,研究组治疗后的微炎性因子指标(hs-CRP、Hb、Alb、TC)及钙磷代谢水平(血钙、血磷)均明显得到改善,且优于对照组,差异有统计学意义(P<0.05)。结论血液透析与血液灌流联合治疗对长期血液透析患者微炎性因子和钙磷代谢的改善有积极作用,值得临床推广。
Objective To investigate the effect of of hemodialysis combined with hemoperfusion on micro inflammatory factor and calcium phosphorus metabolism in long-term hemodialysis patients.Methods From January 2015 to February 201.7,82 cases of long-term hemodialysis patients in our hospital were selected and randomly divided into the control group and the study group,41 cases in each group.The control group was given hemodialysis treatment,the study group was treated with hemodialysis and hemoperfusion combined treatment.The levels of micro inflammatory factors and metabolism of calcium and phosphorus in the two groups were compared.Results After treatment,the micro inflammatory factors （hs-CRP,Hb,Alb,TC） and the level of calcium and phosphorus metabolism （calcium, phosphorus） in the study group were significantly improved,and which was better than that in the control group,with significant difference （P〈0.05）. Conclusion The combination of hemodialysis and hemoperfusion has a positive effect on the improvement of micro inflammatory factor and calcium and phosphorus in long-term hemodialysis patients,which is worthy of clinical promotion.
出处
《中国当代医药》
2017年第12期47-49,共3页
China Modern Medicine
关键词
血液透析
血液灌流
联合治疗
微炎性因子
钙磷代谢
Hemodialysis
Hemoperfusion
Combined therapy
Inflammatory factor
Calcium and phosphorus metabolism
